Top of this page
Skip navigation, go straight to the content

ucb-usa.com Newsroom UCB U.S. News

Categories

  • UCB Statement on COVID-19 Outbreak

    UCB_LOGO_1280x960Patients are at the heart of everything we do, and UCB is committed to helping those impacted by the novel coronavirus, COVID-19. This includes helping patients maintain access to and answering any questions about UCB medicines, as well as putting patient and community care first in all our actions during these uncertain times.

    Read more

  • Like
  • UCB Supports Indiana University Research on Epilepsy Emergency Room Educational Materials

    Posted by Allyson Funk, Head of U.S. Communications & Public Affairs
    UCB_LOGO_1280x960
    The emergency department is a common point of medical intervention for epilepsy patients. We recognize there are more than one million visits to the emergency department every year for epilepsy-related seizures . These visits are not only a significant cost to the healthcare system, but also often leave patients with questions and unease related to their epilepsy diagnosis. The Centers for Disease Control and Prevention (CDC) has also recognized epilepsy as a public health challenge where patients need more skills and resources to manage their condition effectively. That’s why UCB Inc. is working with Indiana University School of Nursing to address existing gaps in care when it comes to emergency department visits and epilepsy care.

    Read more

  • Like
  • Delivering Value for Patients Now and In the Future

    Posted by Katelyn Snider, U.S. Communications and Public Affairs
    LaKeisha_Annual_Report_1280_960_1
    Since 2015, our Patient Value Strategy has been the driver of UCB’s approach to delivering value for patients. Our operational model puts patients and their individual experiences at the heart of everything we do – from discovery to development to delivery.

    Read more

  • Like
  • Recognizing Patients Who Inspire Us

    Posted by Katelyn Snider, U.S. Communications & Public Affairs
    spencer.1280x960
    At UCB, we innovate to bring differentiated solutions with unique outcomes that help specific patients achieve their goals. To do this, we always start with the patient – listening to their experiences, what they value, and what their needs are – keeping them at the heart of everything we do. In honor of Patient Recognition Week, check out a few stories that inspire us to continue to invest in research, expand our scientific understanding, and deliver solutions that provide patients the best individual experience.

    Read more

  • Like
  • UCB: A Decade in Review

    UCB Duane Headshot Blog
    Over the last 10 years, UCB has delivered breakthrough medicines to improve the lives of patients. President and Head of U.S. Operations Duane Barnes, writes about how UCB aspires to innovate for patients over the next decade as we look toward 2030.

    Read more

  • Like
  • UCB’s U.S. Neurology Team Wins EyeForPharma Award for Agile Transformation

    epf.1280x960














    (L to R): Members of the U.S. Neurology Internal Engine Stephanie Hunter-Banks, Jim Hlavenka, Brad Chapman, Trenton Merideth, Tonja Pitts

    UCB’s U.S. Neurology team won a 2019 EyeForPharma award last night in the “Most Promising Agile Transformation” category, which recognizes an experimental initiative that has the potential to disrupt the status quo. The award was presented for the team’s Internal Engine transformation, fulfilling the award criteria of showing agility through rapid creation of a service that touched real customers before being refined and assessed through smart measurement.

    Read more

  • Like
  • Patient-Driven Approach to Innovation

    patient_driven_design_blog_size
    At UCB, our approach to innovation is designed around the patient and their individual experience. Every day, Chris Protos, Solution Enablement Lead, wakes up and thinks about ways we can continue to keep patients at the heart of everything we do. Hear more from Chris about how we’re addressing gaps in patient care through our patient-driven approach to innovation by watching the video below.

    Read more

  • Like
  • What You See Is What You Get

    DenelleWaynick Quote Headshot BlogPost
    UCB's Denelle Waynick, VP, Legal Affairs (U.S.), U.S. General Counsel and Global Head, Enterprise Risk Management, leads by example by being true to herself to encourage others to do so too. Read more from Denelle on why by being authentic to yourself, you become stronger as an individual, leader, and employee. Read the full article on LinkedIn.

    Read more

  • Like
  • UCB PharmD Fellows Have a Big Impact on Patients

    Posted by Katelyn Snider, U.S. Communications & Public Affairs
    Regulatory_Fellows_for_Blog_1280_960
    UCB Global Regulatory Affairs Fellows (L to R): Howraa Alasker, PharmD and Tanya Chaudhri, PharmD, RPh

    The 2020-2022 UCB Global Regulatory Affairs (GRA) PharmD Fellowship Program, a collaboration with the Industry Pharmacists Organization (IPhO), is a 2-year rotational program located at UCB’s Atlanta campus aimed at growing top regulatory talent for the future. Established in 2017, the Fellowship Program is designed to provide PharmD graduates with the opportunity to learn and experience all aspects of regulatory affairs under the mentorship of experienced preceptors. Applications are being accepted now until November 1, 2019. Learn more about the fellowship from current fellow, Tanya Chaudhri, PharmD, RPh.

    Read more

  • Like
  • UCB and University of Washington Collaborate on Engaging Community Pharmacists to Improve Care for People Living with Epilepsy

    Posted by Allyson Funk, Head of U.S. Communications and Public Affairs
    UCB_LOGO_1280x960
    UCB is collaborating with the University of Washington to improve care delivery for people living with epilepsy by engaging community pharmacists.

    Read more

  • Like